期刊文献+

自拟散风通络汤治疗偏头痛对血管收缩与舒张因子的影响 被引量:3

Effect of Sanfeng Tongluo Decoction on Vascular Contractile and Relaxation Factor in Patients with Migraine
下载PDF
导出
摘要 目的:观察散风通络汤治疗偏头痛对血管收缩与舒张因子的影响及临床疗效。方法:选择符合条件的偏头痛病人140例,随机分为治疗组70例和对照组70例,对照组口服卡马西平,治疗组口服散风通络汤,并检测两组治疗前、治疗后4周血管收缩因子血浆内皮素(ET)、舒血管因子一氧化氮(NO)值。结果:经4周治疗,治疗组头痛改善显效率明显高于对照组,治疗后治疗组ET值较对照组显著下降,NO值显著上升,头痛改善显效率亦明显高于对照组(P<0.05),具统计学意义。结论:散风通络汤治疗偏头痛疗效显著,可能通过影响ET、NO水平起作用。 Objective: To observe clinical efficacy of Sanfeng Tongluo Decoction on Vascular contractile and relaxation factor in patients with migraine. Methods : 140 patients with migraine were randomly divided into control group ( 70 cases ), and treatment group ( 70 cases ). The control group was treated with carbamazepine, the treatment group was treated with Sanfeng Tongluo Decoction, plasma endothelin ( ET ) and nitric oxide ( NO )levels were determined before and after 4 weeks of treatment. Results : The significant efficiency for cluster headaches improving of the treatment group was higher than that of the control group. After treatment, ET value in treatment group significantly decreased than that in the control group. Headache improved efficiency was higher than control group. There was statistically significant difference between two groups ( P〈0.05 ). Conclusion : Sanfeng Tongluo Decoction in treatment of migraine has notable curative effect, probably by affecting ET and NO levels.
出处 《辽宁中医药大学学报》 CAS 2012年第4期205-206,共2页 Journal of Liaoning University of Traditional Chinese Medicine
关键词 散风通络汤 偏头痛 血管收缩与舒张因子 Sanfeng Tongluo Decoction migraine vascular contractile and relaxation factor
  • 相关文献

参考文献2

二级参考文献11

  • 1Lipton RB,Diamond S,Reed M,et al.Migraine diagnosis and treatment:results from the American Migraine Study Ⅱ.Headache,2001,41:638-645.
  • 2Silberstein SD.Practice parameter:evidence-based guidelines for migraine headache (an evidence-based review):report of the Quality Standards Subcommittee of the American Academy of Neurology.Neurology,2000,55:754-762.
  • 3Ferrari MD,Roon KI,Lipton RB,et al.Oral triptans (serotonin 5-HT(1B/1 D) agonists) in acute migraine treatment:a meta-analysis of 53 trials/ Lancet,2001,358:1668-1675.
  • 4Headache Classification Subcommittee of the International Headache Society.The Internatiional Classificatiion of Headache Disorders:2nd edition.Cephalalgia,2004,24 Suppl 1:9-160.
  • 5Lawrence EC.Diagnosis and management of migraine headaches.South Med J,2004,97:1069-1077.
  • 6Goadsby PJ,Lipton RB,Ferrari MD.Migraine-current understanding and treatment.N Engl J Med,2002,346:257-270.
  • 7Lipton RB,Stewart WF,Stone AM,et al.Stratified care vs step care strategies for migraine:the Disablility in Strategies of Care(DISC) Study:A randomized trial.JAMA,2000,284:2599-2605.
  • 8Lipton RB,Bigal ME.Migraine:epidemiology,impact,and risk factors for progression.Headache,2005,45:Suppl 1:S3-S13.
  • 9Silberstein SD,Rosenberg J.Multispecialty consensus on diagnosis and treatment of headache.Neurology,2000,54:1553.
  • 10Snow V,Weiss K,Wall EM,et al.Pharmacologic management of acute attacks of migraine and prevention of migraine headache.Ann Intern Med,2002,137:840-849.

共引文献323

同被引文献28

  • 1齐丽莎,杨超,吕云利,王海燕.步长头痛宁对偏头痛患者血浆内皮素和降钙素基因相关肽的影响[J].西北国防医学杂志,2010,31(4):290-291. 被引量:3
  • 2高学敏,钟赣生.临床中药学[M].石家庄:河北科学技术出版社,2004:261-263,286-287.
  • 3王维治.神经病学[M].5版.北京:人民卫生出版社,2004:245
  • 4International Headache Society. The international classification of headache disorders, 3rd edition ( beta version ) [ J]. Cephalalgia, 2013,33(9) :629 -808.
  • 5Evers S, Afra JFrese A. EFNS guideline on the drug treatment of migraine - - revised report of an EFNS task force [ J ]. European Journal of Neurology,2009,16(9) :968 -981.
  • 6Insvold BS, Hagen K, Aamodt AH, et al. Head ache, migraine and cardiovascular risk factors: the HUNT study [J]. Eur J Neurol, 2011,18(3) :504 -511.
  • 7L H Lassen,V B Jacobsen,P A Haderslev,et al. Involvement of calcitonin gene - related peptide in migraine: regional cerebral blood flow and blood flow velocity in migraine patients [J], The Journal of Headache and Pain ,2008,9 ( 3 ) : 151 - 157.
  • 8Dvinsson L, Villalon CM, Maassenvandenbrink A. Basic mecha- nisms of migraine and its acute treatment [J]. Pharmacol Ther, 2012,136(3) :319 -333.
  • 9Ei SH, Fan PC, Kuo PH, et al. Calcitonin gene - related peptide and size of the atrial septal defect in new - onset migraine after transcatheter closure: results of a preliminary study [ J ]. Head- ache ,2012,52 (6) :985 - 992.
  • 10J Zeller,K T Poulsen,J E Sutton,et al. CGRP function -blocking antibodies inhibit neurogenic vasodilatation without affecting heart rate or arterial blood pressure in the rat [J]. British Journal of Pharmacology,2008,155 (7) : 1093 - 1103.

引证文献3

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部